Solid Biosciences LLC
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | – | 100.0% | – | – | – | 100.0% | – | – | – | 100.0% | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 50.0% | 426.0% | 431.6% | 407.8% | 1,399.6% | 36.8% | 11.7% | – | 6.7% | – | – | – | 12.4% | – | – | – | 15.6% | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 50.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | – | 93.3% | – | – | – | -12.4% | – | – | – | -15.6% | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 16.0% | 426.0% | 431.6% | 407.8% | 462.7% | 1,036.1% | 375.7% | – | 263.0% | – | – | – | 326.3% | – | – | – | 985.0% | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 5.7% | 180.4% | 188.3% | 202.0% | 228.6% | 381.9% | 111.1% | – | 94.1% | – | – | – | 143.8% | – | – | – | 292.1% | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 21.7% | 606.3% | 619.9% | 609.8% | 691.4% | 1,418.0% | 511.4% | – | 427.1% | – | – | – | 470.1% | – | – | – | 1,277.1% | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -21.7% | -506.3% | -519.9% | -509.8% | -591.4% | -1,318.0% | -411.4% | – | -427.1% | – | – | – | -470.1% | – | – | – | -1,277.1% | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 0.0% | 0.4% | 0.4% | – | – | 2.3% | 4.7% | – | 244.0% | – | – | – | 41.4% | – | – | – | 2.4% | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -21.7% | -506.7% | -520.2% | -508.4% | -590.0% | -1,315.7% | -406.7% | – | -187.2% | – | – | – | -429.4% | – | – | – | -1,363.5% | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 0.0% | – | 0.4% | 0.0% | -2.0% | -2.3% | -4.7% | – | -244.0% | – | – | – | 96.3% | – | – | – | 30.5% | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -21.7% | -506.7% | -520.2% | -508.4% | -590.0% | -1,315.7% | -406.7% | – | -187.2% | – | – | – | -429.4% | – | – | – | -1,363.5% | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -20.9% | -484.3% | -499.8% | -487.2% | -565.9% | -1,278.9% | -375.1% | – | -350.5% | – | – | – | -424.9% | – | – | – | -1,345.5% | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.